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Background: Obesity is associated with a mild chronic inflammatory
response, which has been suggested to be pivotal in the development of
cardiometabolic alterations of obesity. However, little is known about the
involvement of acute inflammation.
Objective: To evaluate whether circulating neutrophils, markers of acute
inflammation, are associated (quantitatively and qualitatively) with adolescent
obesity and whether leptin modulates these associations.
Subjects and methods: We assessed 528 adolescents (16.8 yr old, 47% females),
without chronic/acute illness. We measured anthropometry and dual energy
X-ray absorptiometry and calculated fat mass percentage (FM%). Fasting
serum glucose, high-density lipoprotein (HDL)-cholesterol, and triglycerides
were used with blood pressure and waist circumference to compute a
metabolic z-score. Leukocyte and neutrophil counts were obtained, together
with levels of serum leptin. In a subsample of 23 males, flow cytometry was
used to assess degranulation (CD66b expression) of neutrophils.
Results: Female sex and obesity were positively related to mean neutrophil
counts (p< 0.05). When accounting for sex and weight status, leptin was
associated with neutrophil counts (p< 0.05), partially explaining the
association between obesity and neutrophil counts. Neutrophil counts were
related to metabolic risk z-scores, controlling for fat mass. Participants with
elevated FM% showed more neutrophil degranulation than controls
(p< 0.05).
Conclusions: Participants with increased adiposity had higher circulating
neutrophil counts, suggesting acute inflammation. Furthermore, the
neutrophils showed more degranulation, indicating inflammation.
Obesity-induced alteration of the adipose secretory pattern (i.e., changes in
leptin levels) could be involved in acute inflammation.
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Childhood obesity is a worldwide problem with
increasing prevalence and severity (1). Obese children
are more likely than their non-obese counterparts to
have risk factors for later cardiovascular disease (2). As
in adults, childhood obesity has been associated with
a mild chronic inflammatory state (3, 4). Inflammation
may be the mediator between excess fat mass and
the metabolic/cardiovascular alterations that lead to
atheromatosis (3, 5, 6), the development of plaque on
degenerated thickened arterial intima. Atheromatosis
is itself an inflammatory process (7).
Both total and differential leukocyte counts have
been used to assess obesity-triggered inflammation.
Total leukocyte counts are higher in obese subjects
(8–10), and have been related to unfavorablemetabolic
profiles (9, 11) and cardiovascular events (12, 13), after
adjusting for body mass. The association of leukocyte
counts with worse metabolic and cardiovascular
outcomes could be explained, in part, by increased
influx of leukocytes into adipose tissue, intimal
atheromatous plaques, and key organs including the
pancreas (5, 12, 14). Decreasing specific circulating
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leukocyte subtypes in murine models reduces their
influx into the subendothelial space, thereby reducing
the size of atheromatous lesions (15, 16).
Much research has focused on the study of
circulating monocytes, the macrophage precursors
(17), becausemacrophages are characteristic of chronic
inflammation and the main leukocyte subtype that
infiltrates tissues in obesity. In humans, the counts
of classical subtype of circulating monocyte (i.e.,
CD14++ CD16−) have been shown to predict
ischemic cardiovascular events (18). In addition,
inflammatory changes can be seen in neutrophils,
pathognomonic of acute inflammation. In obesity,
circulating neutrophil counts are elevated (4, 10,
19, 20) and neutrophils are also increased in
blood vessels from adipose tissue biopsies (21, 22).
Moreover, their inflammatory status is exacerbated
in obese subjects. The inflammatory status of
neutrophils can be measured through the evaluation
of phagocytosis, oxidative burst, and secretion of
pre-formed proteins contained in secretion granules
and vesicles. Neutrophils of obese compared to
those of non-obese subjects show greater surface
expression of the protein CD66b, which is secreted into
specific granules (23), indicating greater degranulation
(22). In addition, neutrophils from obese subjects
have increased oxygen reactive species, indicating
oxidative burst, and greater phagocytosis (24).
Additionally, neutrophils have been identified in
leukocyte infiltration of key tissues in murine models
(e.g., adipose tissue and endothelium) (16, 25). In
humans, the number of neutrophils in circulation
predicts cardiovascular events, even after adjusting
for body mass index (13).
The triggers of chronic inflammation in obese
individuals are not well understood. The permanent
nutritional surplus, associated with overnutrition,
results in ongoing intracellular stress, which in turn
increases the expression of inflammatory markers in
several cell types (26). The involvement of actors of
acute inflammation is also challenging to understand.
As neutrophils have a short lifespan from a few hours
to days (27), the existence of active triggers influencing
both increased numbers and increased inflammatory
status can be assumed. Obesity may result in a change
in the secretory profile of adipokines (i.e., leptin) that
may have a role in the modulation of the immune
response (28).
As total and differential leukocyte counts are
relatively low cost and available for sampling, the
quantitative study of circulating leukocytes could be
an attractivemethod formonitoring obesity-associated
cardiometabolic risk. However, there are important
barriers to this approach. Inter-individual variability
and the wide range of normal values make it difficult
to isolate the influence of obesity. Additionally, other
factors influence leukocyte numbers including illness
and age (4). There are also sex differences associated
with the pro-inflammatory properties of estrogens
(29), thus leukocyte counts can vary according to
menstrual cycle or oral contraceptive use. In order to
overcome these barriers larger sample sizes are needed.
Another approach would be to study the qualitative
characteristics of leukocytes, using more sophisticated
techniques (e.g., flow cytometry or functional assays).
In a sample of healthy adolescents, our purpose
was to: (i) confirm the presence of obesity-associated
increase in neutrophil counts as a marker of acute
inflammation, exploring the potential role of leptin
levels; (ii) examine whether higher neutrophil counts
were associated with a composite metabolic risk
score; and (iii) determine whether inflammatory
characteristics of neutrophils were associated with
adiposity in a subsample of male participants.
Methods
Participants
This observational cohort study included Chilean
adolescents between 16- and 17-yr old. Participants
were enrolled as infants in a randomized controlled
trial of iron supplementation to prevent iron deficiency
anemia, in Santiago, Chile, from 1991 to 1996.
A detailed description of randomization techniques,
sampling, and entrance and exclusion criteria for
the original preventive trial is published elsewhere
(30). Participants have been studied at 5, 10, and
16 yr. For the current cross-sectional study, we
examined the 16-yr follow-up data, which included
679 adolescents assessed between 2009 and 2012. We
excluded participants that reported any chronic or
acute illnesses (in the last week) and those who had
high sensitivity C-reactive protein (hsCRP) levels over
9mg/L, since these values are suggestive of an acute
infectious process. The final analytical sample included
528 participants. The studied subgroup did not differ
from the 679 evaluated participants in terms of gender,
nutritional status, or metabolic status. Because of
the exclusion criteria, the groups differed in their
inflammatory parameters (e.g., hsCRP). Parents signed
informed consent and adolescents signed informed
assent. Ethics Boards at the Institute of Nutrition
and Food Technology, University of Chile (INTA),
University of California, SanDiego, and theUniversity
of Michigan approved this study.
Anthropometry, body composition, and blood
pressure
Two trained physicians performed the anthropometric
and blood pressure measurements. Weight and
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height were assessed in duplicate with a Precision
Hispana scale and a stadiometer accurate to 0.1 kg
and 0.1 cm, respectively. Participants were measured
without shoes, wearing underwear, in the Frankfurt
position. Sex- and age-specific body mass index z-
scores (BMIz) were calculated using World Health
Organization (WHO) growth standards. Weight status
was categorized as follows: BMIz< 2= non-obese;
BMIz≥ 2= obese. Blood pressure was measured
with standard procedures and the average of 2–3
measurements was computed.
Total fat mass was assessed using Lunar Prodigy
Dual Energy X-Ray Absorptiometry scan (DXA,
Lunar Prodigy instrument; General Electric Medical
System, Madison, WI, USA). All participants were
measured according to standard protocols on the
same machine calibrated every other day. Fat
mass percentage (FM%) was calculated [fat mass
(kg)× 100/body mass (kg)], and categorized as normal
(<20%) or elevated (≥20%).
Blood sample processing
Blood samples were obtained after an overnight
fast (10–12 h). Enzyme-linked immunosorbent assay
(ELISA) was used for determining serum levels of lep-
tin (DRG International, Inc., New Jersey, NJ, USA;
1 ng/mL sensitivity). hsCRP was assessed by immuno-
turbidimetry (QCA S.A. Amposta, Tarragona, Spain,
0.02mg/L sensitivity). Serum triglyceride, high-density
lipoprotein (HDL)-cholesterol, and glucose levels were
determined using an enzymatic-colorimetric test (QCA
S.A., Amposta). Total leukocyte counts were obtained
using an automated leukocyte counter (CELL DYN
3200, Abbott Laboratories, Abbott Park, IL, USA)
from ethylenediaminetetraacetic acid (EDTA)-treated
blood. Blood smears were analyzed for differential
leukocyte percentage by an experienced researcher,
blinded to participant anthropometric data. Neu-
trophil counts were further categorized as upper
quartile (≥75th percentile) or not (<75th percentile);
percentiles were calculated separately by sex.
In a subsample of 23 male participants, the inflam-
matory characteristics of neutrophils (CD16b positive
cells) were assessed by looking at the surface expression
of the degranulation marker CD66b through flow
cytometry. EDTA-treated whole blood was stained
with anti CD16b-PE (BD Becton Dickinson; Franklin
Lakes, NJ, USA) together with CD66b-FITC or
isotype control (Biolegend; San Diego, CA, USA)
within 2–3 h of the blood draw. Red blood cells were
lysed (BD Becton Dickinson), washed with phosphate
buffered saline (PBS), and centrifuged. Stained cells
were stored at 4◦C in formalin fixative and protected
from light until analysis in a flow cytometer (CyAn™
ADP; Beckman Coulter Inc., Brea, CA, USA), within
48 h of staining. Analyses were conducted indepen-
dently by two researchers using Summit V4.3 software
(Dako, Colorado Inc., Fort Collins, CO, USA). Mean
fluorescent intensity (MFI) was calculated in positive
cells as the mean fluorescence of CD66b divided by
the MFI of cells from the same donor stained with the
isotype control.
Statistical analysis
A metabolic syndrome risk z-score was constructed
for the whole sample adapted from the work of Brage
et al. (31) as previously reported (32), averaging the
z-scores of: the reciprocal of HDL cholesterol, mean
of systolic and diastolic blood pressure measurements,
waist circumference, triglycerides, and glucose.
We used non-parametric statistics for skewed
variables and for analyses of the subsample of 23
participants. Comparisons of continuous variables
between groups were evaluated using t-tests or
Mann–Whitney tests, as appropriate. Comparisons
were adjusted for fat mass using ancova when appro-
priate: (i) comparisons between males and females
in leukocytes and neutrophils counts, given the sex-
related body composition differences and since fatmass
content influences blood cell count; (ii) comparisons in
metabolic z-score between groups based on sex-specific
quartiles for neutrophils count. Categorical variables
were compared using chi-squared tests. Bivariate
correlations (Spearman) were also used. Finally, in
order to explore factors associated with the circulatory
number of neutrophils, we made multivariable asso-
ciations (linear models) assessing the influences of sex
and obesity, further exploring whether leptin modified
the associations. All analyses were performed using
spss for Windows (version 20.0, Chicago, IL, USA). p
values <0.05 were considered statistically significant.
Results
Participants were 16.8 yr old (range 16.4–18.1) and
47% were female. Fifteen percent of participants were
obese. Comparisons between gender and weight status
are shown in Table 1. Mean BMIz did not differ by
sex, nor did the proportion of obese participants (chi
square; p= 0.52). As expected, fat mass and leptin were
significantly higher among females compared to males.
WBC count, neutrophil count, and percentage were
also significantly higher among females compared to
males. Neither hsCRP nor metabolic z-score differed
significantly between males and females.
Stratified by sex, obese, compared to non-obese,
participants showed greater hsCRP, WBC, and
neutrophil counts (the latter only among males). As
expected, leptin levels were also affected by weight
status, with an increase in leptin levels among obese
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Table 2. Modeling neutrophil count (103/μL)
Model 1 Model 2
Beta p value Beta p value
Female (ref=male) 837.9 <0.001 697.9 <0.001
Obesity (ref= not obese) 332.6 0.04 201.2 0.24
Leptin – – 11.3 0.03
Fig. 1. Metabolic risk z-score according to neutrophil count.
Percentiles calculated separately for males (≥4054.7× 103/μL) and
females (≥5045.6× 103/μL). Metabolic risk z-score for computed as
averaging the z-score of: the reciprocal of high-density lipoprotein
(HDL)-cholesterol, mean of systolic and diastolic blood pressure
measurements, waist circumference, triglycerides, and glucose.
*ancova, adjusted for fat mass percentage, p=<0.01.
participants of both sexes. In females and males, wide
ranges of leptin levels were observed: 1.0–73.1 ng/dL
in non-obese subjects and 1.0–76.9 ng/dL in obese
participants. Obese males and females had a
significantly highermetabolic z-score compared to their
non-obese counterparts (Table 1). Differences in WBC
and neutrophil counts between males and females were
not explained by body composition since differences
associated with sex remained significant after adjusting
for FM% (ancova; both p< 0.05).
Table 2 showsmultivariable linear regressionmodels
predicting neutrophil count. Adjusting for obesity and
sex, females had 837.9× 103/μL more neutrophils
compared to males, and obese participants had
332.6× 103/μL more neutrophils compared to non-
obese (Model 1). When leptin was added to the model
as a covariate (Model 2), the relationship between
neutrophil counts andobesitywasno longer significant.
As shown inFig. 1, participantswith a neutrophil count
in the highest quartile (sex-specific) had a significantly
greater metabolic z-score, after adjusting for fat mass.
Descriptive statistics of the male subsample are
shown in Table 3. Inflammatory characteristics did
not differ according to fat mass status (normal
FM< 20% vs. elevated FM≥ 20%). Leptin levels and
metabolic z-scores were significantly higher among
participants with elevated fat mass. Most neutrophils
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Table 3. Variables* according to fat mass status† in a subsample of male participants (n=23)
Overall Normal FM (n= 5) Elevated FM (n=18) p value‡
BMI z-score 1.4 (0.8–1.9) −0.4 (−1.2–0.6) 2.0 (1.4–2.3) <0.001
FM% 27.4 (23.6–30.4) 15.8 (13.6–19.2) 31.1 (27.0–32.9) <0.001
Waist circumference, cm 85.3 (80.5–90.0) 73.7 (71.4–75.9) 88.5 (83.4–93.6) <0.01
WBC, 103/μL 5890.0 (5550.0–6516.1) 6140.0 (4474.6–7365.4) 5835.0 (5499.4–6629.5) 0.85
Neutrophils, 103/μL 3250.0 (3013.7–3739.6) 3585.0 (2158.3–4410.4) 3249.0 (2981.8–3822.8) 0.91
Neutrophils, % WBC 55.0 (52.0–60.1) 55.0 (43.1–67.3) 56.0 (51.6–61.0) 0.69
hsCRP, mg/L 0.5 (0.6–1.6) 0.38 (−0.0–1.1) 0.78 (0.6–1.9) 0.25
Leptin, ng/mL 2.2 (2.6–7.5) 1.0 (0.6–1,9) 3.2 (3.1–9.1) 0.01
MetS z-score 0.0 (0.0–0.5) −0.1 (−0.6 to 0.34) 0.5 (0.1–0.7) 0.03
BMI, body mass index; FM, fat mass; hsCRP, high-sensitive C-reactive protein; MetS: z-score for metabolic variables
computed as averaging the z-scores of: the reciprocal of HDL cholesterol, mean of systolic and diastolic blood pressure
measurements, waist circumference, triglycerides, and glucose; WBC, white blood cells.
*Values represent median and (95% CI).
†Normal FM=<20%, Elevated FM=≥20%.
‡Mann–Whitney.
expressed the degranulation marker CD66b (99.2%),
without differences between groups (Mann–Whitney;
p= 0.40); however, the fluorescence intensity (i.e., the
amount of CD66b that was expressed on neutrophil
surfaces) was significantly greater among adolescents
with elevated fatmass (MFI= 8.9 vs. 22.9) compared to
the normal fat mass group (Fig. 2). Moreover, fat mass
and CD66b expression were significantly correlated
(Spearman; r= 0.4; p= 0.03).
Discussion
In our sample of Chilean adolescents, obese
participants showed not only increased levels of
classical inflammatory markers (i.e., hsCRP in
the subclinical inflammation range and elevated
WBCs), indicating chronic inflammation, but also
higher numbers of circulating neutrophils, suggesting
acute inflammation. We found that leptin levels
partially explained the association between obesity
and neutrophil counts. Greater neutrophil counts were
associated with worse metabolic z-scores, even after
controlling for fat mass. Moreover, participants with
high FM% had circulating neutrophils in a greater
inflammatory state compared to those with normal
fat mass.
While it is well accepted that childhood obesity
is a chronic inflammatory condition (3, 4, 8), little
attention has been paid to the involvement of
neutrophils, characteristic of acute inflammation. The
recent implication of this leukocyte subtype in the
pathogenesis of atherosclerosis (16) suggests that
increases in circulating numbers could be related to
the development of future morbidity.
Our data showed higher neutrophil counts in female
compared to male participants, an association not
explained by fat mass. The increased inflammatory
state in females might be explained by the pro-
inflammatory influence of estrogen (29), a hormone
that should be accounted for in future studies. Skinner
et al. also found higher neutrophil counts in girls and
adolescent females compared to boys and adolescent
males (4). To our knowledge, no other studies have
stratified similar data by gender (11, 20). The well-
reported cardioprotective effect of estrogens seems to
contradict the pro-inflammatory effects, highlighting
that our understanding of cardiovascular risk factors
is only emerging.
There is evidence in humans linkingobesity-triggered
inflammation with cardiometabolic alterations, after
accounting for adiposity. As not all obese individuals
develop cardiovascular disease or insulin resistance,
it is possible that the development of the pathology
depends on the involvement of the immune system.
Markers of this involvement include macrophages
infiltrating visceral adipose tissue (5), circulating
leukocytes (11, 19), and hsCRP (6). In our sample,
participants whose neutrophil counts were in the
highest quartile had worse metabolic scores, after
adjusting for fat mass. Neutrophil counts have been
previously associated with cardiometabolic outcomes
among adults, independent of fatmass orweight status.
Reports show that neutrophil counts are positively
associated with insulin levels (33), are increased among
patients with metabolic syndrome (34), and predict
cardiovascular events (13). We are not aware of other
reports in a pediatric population.
In our study, obesity was associated with neutrophil
counts, and leptin explained some of the variance in
this association. The ranges of leptin values among
non-obese and obese participants were large and
overlapping. Our results suggest that variance in
neutrophil counts is more associated with leptin values
than with weight status when sex is taken into account.
Other reports have shown that total leukocyte counts
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Fig. 2. Basal neutrophil degranulation according to fat mass category in a subsample of male participants (n= 23). Main figure: Surface
expression of CD66b in granulocytes (CD16b+ cells) by flow cytometry performed in fresh whole blood samples [ratio of CD66b-FITCmedian
fluorescence intensity (MFI) and isotype control MFI]. Normal fat mass <20%, elevated fat mass ≥20%. Boxes represents median (black line)
and 25th and 75th percentile and error bars represents range for CD66b surface expression. *Mann–Whitney: p= 0.015. Inset: Representative
histogram of fluorescence intensity in FL1 for granulocytes. Isotype control (light gray line), CD66b-FITC from a low fat mass donor (dark
gray line), CD66b-FITC from an increased fat mass donor (black line).
are positively associated with leptin after controlling
for weight status (35). However, to our knowledge,
this is the first study showing an influence of leptin on
neutrophil counts, even though this adipokine has been
previously suggested as a granulopoiesis stimulator in
animals (36). Additionally, in vitro leptin stimulation
of neutrophils has been shown to be a trigger of
chemotaxis and oxidative burst (37), and an inhibitor
of apoptosis (38), with at least one report of no effect
at physiological doses (39).
In addition to assessing the quantitative effect
of obesity on neutrophils, we wanted to explore
whether these acute inflammatory cells were in a
greater inflammatory state in those with obesity. We
did this by assessing the surface expression of the
degranulation marker CD66b. Given the influences
of sex on neutrophil counts, we decided to study
this in male participants only. The subsample studied
showed a significant association between fat mass
and neutrophil degranulation. Neutrophils from obese
patients are expected to have increased adherence (40),
phagocytosis and oxidative bursts (24). In line with our
results, Nijhuis et al. showed that severely obese adults
have greater expression of CD66b (22). However, other
authors have reported no change or even a decrease
in the expression of different adhesion molecules in
neutrophil surface (41). Thus, the effect of obesity may
differ depending on the marker analyzed. Given the
size of the subsample, we were not able to evaluate
whether leptin mediated degranulation of neutrophils.
Our study has several limitations. We did
not assess whether female participants were using
hormonal contraception, which could have influenced
inflammatory status. The small subsample, in which we
studied surface expression of the degranulationmarker
CD66b using flow cytometry, was composed of only
males. This was necessary due to the potential effects of
the timing of themenstrual cycle or the use of hormonal
contraceptives. We used an adaptation of the work of
Brage et al. (31), which includes waist circumference,
but not skinfold thickness or insulin. Comparisons
with other published work should take this into
consideration. Another limitation is the cross-sectional
nature or our study. The strengths of this study
include that the analyses were based on a large sample
of 528 adolescents with data on body composition.
As participants belong to a cohort that is being
followed from adolescence into adulthood to assess the
development of cardiometabolic alterations, next steps
could include studying how baseline neutrophil levels
and functioning influence the incidence and severity of
the comorbidities of obesity.
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In conclusion, overweight and obese adolescents
had a higher number of circulating neutrophils,
suggesting that obesity triggers acute inflammatory
changes. A higher neutrophil count was associated
with worsemetabolic condition after controlling for fat
mass. Moreover, in a subsample of male adolescents,
participants with elevated FM% had increased
inflammatory status in their circulating neutrophils,
providing more evidence that overnutrition is
associated with acute inflammation. Obesity was no
longer significantly associated with neutrophil counts
when leptin was included in the model, suggesting that
alterations in the secretory profile of adipose tissue
may be involved in the acute inflammatory changes
observed. Neutrophils appear to be an attractive
target for future studies of the role of obesity in the
development of inflammation.
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